IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Tri Locum Partners LP

Portfolio Profile

CIK: 0001826434 | NEW YORK, NY

Investment Profile

Style

Growth

Turnover

Very High

Orientation

Concentrated trader
$813.2M
AUM
19
Positions
80%
Top 10 Conc.
100%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Johnson & Johnson(JNJ)424,945$107.9M13.27%
2Vertex Pharmaceuticals Inc(VRTX)201,791$100.2M12.33%
3ELI Lilly & Co(LLY)76,532$91.8M11.29%
4Ascendis Pharma A/S(ASND)258,740$69.0M8.49%
5Dexcom Inc(DXCM)820,479$55.3M6.80%
6

Sector Allocation

Latest filing, equity positions only

Healthcare93.43% · $759.8M
Unclassified6.57% · $53.4M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare95.79%93.43%-2.36%
Unclassified4.21%6.57%+2.36%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$312.8M | 61 pos.
$218.8M | 24 pos.
$288.4M | 27 pos.
$395.5M | 25 pos.
$417.4M | 20 pos.
$482.7M | 28 pos.
Axsome Therapeutics Inc.(AXSM)
219,308
$53.7M
6.60%
7Jazz Pharmaceuticals PLC(JAZZ)221,720$53.4M6.57%
8Enliven Therapeutics Inc(ELVN)866,716$44.0M5.41%
9Argenx SE(ARGX)41,596$38.6M4.75%
10Madrigal Pharmaceuticals Inc(MDGL)68,273$36.7M4.51%
Cap SizePrev %Curr %Change
Large Cap62.5%48.95%-13.55%
Mega Cap22.2%24.56%+2.36%
Mid Cap11.09%13.56%+2.47%
Unclassified4.21%6.57%+2.36%
Small Cap0%6.36%+6.36%
$194.9M | 22 pos.
$329.5M | 23 pos.
$435.1M | 18 pos.
$770.1M | 15 pos.
$712.5M | 17 pos.
$813.2M | 19 pos.
Q3
23
Q4
23
Q1
24
Q2
24
Q3
24
Q4
24
Q1
25
Q2
25
Q3
25
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

5
New
3
Closed
8
Increased
6
Decreased
0
Unchanged